Urologix Inc (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,419 | -1,334 | -4,292 | -3,045 | -2,040 |
| Depreciation Amortization | 302 | 157 | 674 | 505 | 339 |
| Income taxes - deferred | 18 | 7 | 1 | 32 | 22 |
| Accounts receivable | 247 | 30 | 23 | 44 | -92 |
| Accounts payable and accrued liabilities | 426 | 485 | 1,760 | 2,607 | 1,599 |
| Other Working Capital | 839 | 286 | 1,092 | 1,652 | 797 |
| Other Operating Activity | -403 | -365 | -1,217 | -2,345 | -1,411 |
| Operating Cash Flow | $-990 | $-734 | $-1,959 | $-550 | $-786 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -2 | -79 | -55 | -36 |
| Net Acquisitions | N/A | N/A | -1,368 | N/A | N/A |
| Purchase Sale Intangibles | -6 | -3 | -32 | -24 | -12 |
| Other Investing Activity | -6 | -3 | -32 | -24 | -12 |
| Investing Cash Flow | $-33 | $-5 | $-1,479 | $-79 | $-48 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 3,829 | 3,830 | 3,814 |
| Financing Cash Flow | $N/A | $N/A | $3,829 | $3,830 | $3,814 |
| Beginning Cash Position | 2,290 | 2,290 | 1,899 | 1,899 | 1,899 |
| End Cash Position | 1,267 | 1,551 | 2,290 | 5,100 | 4,879 |
| Net Cash Flow | $-1,023 | $-739 | $391 | $3,201 | $2,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -990 | -734 | -1,959 | -550 | -786 |
| Capital Expenditure | -27 | -2 | -79 | -55 | -36 |
| Free Cash Flow | -1,017 | -736 | -2,038 | -605 | -822 |